BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.

about

Mechanism of action of trabectedin in desmoplastic small round cell tumor cells.Biomechanical regulation of drug sensitivity in an engineered model of human tumor.Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations.

P2860

Q36272148-65A84CFE-C65D-4963-8D8C-63CC10D962E3 Q47436328-0086ACA7-5FEA-4EFE-949D-DFDFE55B115C Q55033636-884DE851-1D34-4390-8CA8-8CA721D45230

P2860

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.

Item

http://www.wikidata.org/entity/Q39985326

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

BO-1055, a novel DNA cross-lin ...... nt activity in sarcoma models.

@en

BO-1055, a novel DNA cross-lin ...... nt activity in sarcoma models.

@nl

type

Item

label

BO-1055, a novel DNA cross-lin ...... nt activity in sarcoma models.

@en

BO-1055, a novel DNA cross-lin ...... nt activity in sarcoma models.

@nl

prefLabel

BO-1055, a novel DNA cross-lin ...... nt activity in sarcoma models.

@en

BO-1055, a novel DNA cross-lin ...... nt activity in sarcoma models.

@nl

P1476

BO-1055, a novel DNA cross-lin ...... nt activity in sarcoma models.

@en

P2093

Anisha Chaudhry

http://www.w3.org/2001/XMLSchema#string

Ashish Saxena

http://www.w3.org/2001/XMLSchema#string

Benet Pera

http://www.w3.org/2001/XMLSchema#string

Elissa W P Wong

http://www.w3.org/2001/XMLSchema#string

Eloisi Caldas Lopes

http://www.w3.org/2001/XMLSchema#string

Jae-Hung Shieh

http://www.w3.org/2001/XMLSchema#string

Malcolm A S Moore

http://www.w3.org/2001/XMLSchema#string

Srikanth R Ambati

http://www.w3.org/2001/XMLSchema#string

Tsann-Long Su

http://www.w3.org/2001/XMLSchema#string

P2860

Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas

Children's Oncology Group's 2013 blueprint for research: bone tumors

Clonal evolution in cancer

Drug combination studies and their synergy quantification using the Chou-Talalay method

Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry.

Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

Patient-derived xenograft models: an emerging platform for translational cancer research

Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.

P304

43062-43075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9657

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27248664

http://www.w3.org/2001/XMLSchema#string

P932

5190008

http://www.w3.org/2001/XMLSchema#string

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.

about

P2860

P2860

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932